{"name":"Eisai Limited","slug":"eisai-limited","ticker":"","exchange":"","domain":"eisai.com","description":"Eisai Limited is a subsidiary of Eisai Co., Ltd., a global pharmaceutical company with a focus on neurology and oncology. The company is dedicated to discovering and developing innovative therapies to address unmet medical needs, particularly in areas such as epilepsy and cancer.","hq":"","founded":0,"employees":"~XX,000","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Eribulin-LF","genericName":"Eribulin-LF","slug":"eribulin-lf","indication":"Other","status":"phase_1"},{"name":"E7449 plus carboplatin and paclitaxel","genericName":"E7449 plus carboplatin and paclitaxel","slug":"e7449-plus-carboplatin-and-paclitaxel","indication":"Other","status":"phase_1"},{"name":"MENATETRANONE","genericName":"MENATETRANONE","slug":"menatetranone","indication":"Other","status":"marketed"},{"name":"Iomeprole","genericName":"Iomeprole","slug":"iomeprole","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Eribulin-LF","genericName":"Eribulin-LF","slug":"eribulin-lf","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E7449 plus carboplatin and paclitaxel","genericName":"E7449 plus carboplatin and paclitaxel","slug":"e7449-plus-carboplatin-and-paclitaxel","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MENATETRANONE","genericName":"MENATETRANONE","slug":"menatetranone","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Iomeprole","genericName":"Iomeprole","slug":"iomeprole","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPVWhhaFFDNDNVbWRhNGVTMG54TFRRTmRyTFhyM1dUZ1pIbUlUdVNMZFlXcE03RWhUc0pVUlBjdWpqcGJUSzNaV0NsOFFtd3NTNUpfdWVOcDNZYzcyajRDSlNqWGVMZU9iVXNsQTRJRnphSG1CNFZSbU40aEFEWXJyZTUyRml0ZWNveUJIU1dCRVk0R2xiXzF0azdIZFI3ZmNsLV9uNFdCZkM5VEJieTVnVmxNNjZCU3FWelBTTzNn?oc=5","date":"2026-04-02","type":"pipeline","source":"AD HOC NEWS","summary":"Eisai Co Ltd Stock: Japanese Pharma Leader Focused on Neurology with Global Reach for North American - AD HOC NEWS","headline":"Eisai Co Ltd Stock: Japanese Pharma Leader Focused on Neurology with Global Reach for North American","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNRG12S3NpMEktUmxVUjBCdlhJRFljTjNZbUhFVkZWd05OcVVvTFFNTVdUSDNzTW1BMHQ3U3VjejB1bGlSYTAzQ3k4OFZSa1Q3dHBMbDB1LXRQZHh3Tjl1YVB6LV9hakhBM1BudWRKT3NIOUYtY0t2TUJoWFl4ZHgzUkdwb0g4U2xncEtJOEQ5OExrZVNWT051YTF0QTQwU3lFSFczNS1kZDhwZjZZdnUyRHR1YTU0UVBWZHRDbVJxcDRGU3N4SUxNNGs5Yk90V3JGbEhrRzc3dENOeVlDNC1NVEJWS3hOckZZUkYtaXRPX1RwdWRiTmZib21QcVpJYWM?oc=5","date":"2026-01-13","type":"deal","source":"Citeline News & Insights","summary":"Asia Deal Watch: Eisai Obtains Rights To Nuvation’s Ibtrozi Outside US, Japan, China - Citeline News & Insights","headline":"Asia Deal Watch: Eisai Obtains Rights To Nuvation’s Ibtrozi Outside US, Japan, China - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxNSXBvSjJ0ckFhWDFIZ2k2dENaVkowZGQ3enVNNHpITHNoamVKREEzSXgzSmRJSUEzOXA1S01sSmttMHlUUjNCczJ4TklrSHVoYmlwMm92QnRtT2drNHVBVEM2Z0pxbExKdFdJSnkwSV9IM1RmNm1KcU1sQkVveERDcUpsdTdiTFNGbWJub0FaQ2NiU1ZaNnNQR0ZXZzhNQUYzbjFuZFBLNG5vSko4eUd1TTNfSkxnQWkyZ1hIU2dnMDllQlZWalNMWHNvZ2RHOG9vSFhST09Wc3gwSEkyZjdROVRBcS1GTUk0VHp6U1U2Vlo5YU5qc2xNT0F2LS1HVC1pVTR3NFZsNE13eVJUUThVRGtjMXVTOWs?oc=5","date":"2026-01-07","type":"trial","source":"BioSpace","summary":"EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan - BioSpace","headline":"EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPQ2dHS2pzZ2lxekJ2VW5uQlFPTHBDcWtIeWxkdk5sVHQ3cVZRNkRrUlV4SHdGd3l1SUlEN1B6UGR3N1JzYXFZRHk1ZVBjejNBUHZBMzlhUVFIVUdyWHJydkV6QUphbGZCYmhuYmpnYWxCaEVSQzNNenlfeVp0dEJ5WVp3ak5BbmxmREltdXdBSFNlQXRqM0dnR3dsS2JlNHgwd29oRjBhMzR5ZWx4cmVpbE9fbkFNdjQ?oc=5","date":"2026-01-04","type":"pipeline","source":"AD HOC NEWS","summary":"Eisai Co Ltd Is Quietly Exploding – Here’s Why Smart Money Won’t Shut Up About It - AD HOC NEWS","headline":"Eisai Co Ltd Is Quietly Exploding – Here’s Why Smart Money Won’t Shut Up About It","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-04","type":"trial","source":"Medical Dialogues","summary":"Submit Full Adverse Event Data from Lenvatinib Phase IV Liver Cancer Trial: CDSCO Panel To Eisai Pharma - Medical Dialogues","headline":"Submit Full Adverse Event Data from Lenvatinib Phase IV Liver Cancer Trial: CDSCO Panel To Eisai Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPWlZPYVBnUDJQbWwwNDA5ZUVYUlJXNDQwZWh3OW1YcTFuQ1Y2aEItQTRuRDhRTU5PU0Q4OGR4c2Q5UjlPQUxMNFFpRUxLX1p5VWxFaEM1dmJKX3ZTTTFnUkdqVUhadFNjeDNIYXF0T2pzVHpMbHZVbUtpMXNoV19XeEhudG5IV1pCVnJRcEduZjRVVFNDell1Y29iSzFKeGlSOC1TRDZsU0VwdmNtRG5PRmF3ZG5EeElRVE5ZUVFOU3M2QnlSQ3FSTWdqQnFnM0E1eWdsTHA0V0FEU284SHRsNVA1UDVhR0xvN29oRQ?oc=5","date":"2025-07-03","type":"earnings","source":"Mississauga.com","summary":"Another pharmaceutical giant expands Canadian headquarters in Mississauga - Mississauga.com","headline":"Another pharmaceutical giant expands Canadian headquarters in Mississauga","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPM3lRYU5ZTk1HLUgxb1dHRkYtR0syNXI1RjY5b2RJTzJyd1BjUFdkbEprTm14SEk0RzMzd2ZsOFZfM2w3emlXZ1JLZ3JySlFqRkxzYnpaTHA0LURrWndLRFluZE9yTDdmZ3VTV0Y3YmhiVUtwaEkwZmQ1UlZJZWhIMGJObXZIMUc5c3pqaVp0ZGphekV2M1NiTUhpdUJ5QlFDNXFMYlZCb2tPUTcyTzVpRWdLN3hTb1YzTUhoVGo3MjVKTGJnNTNz?oc=5","date":"2025-06-23","type":"pipeline","source":"Newswire Canada","summary":"Eisai Limited Bolsters Canadian Operations with Major Mississauga Expansion - Newswire Canada","headline":"Eisai Limited Bolsters Canadian Operations with Major Mississauga Expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9zMVhvSXZ1ZzlVVnI5aFdVT1Q4R29udjl0OW5NUWYtUHltTU5EcjJaQ1d3STE4czZDZlo2VEFIdWRsbkNoV3VSZndWdkhHdkVHQ0Y0aGc1ejNUT2MxMjc2eXRLSVZ2aTZvdFlKNmttWnpkM20xbEE?oc=5","date":"2023-06-07","type":"pipeline","source":"The Record from Recorded Future News","summary":"Japanese pharma giant Eisai working with law enforcement to resolve ransomware attack - The Record from Recorded Future News","headline":"Japanese pharma giant Eisai working with law enforcement to resolve ransomware attack","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxPZWY0aXZMb0ZRUFVfN1o3VkZHd3UxeG42RUdCbC1EZVhiSTNHbTQ3VXNwZGp4Si1nQ0R4UWswblNLVlAxbFB5Qkh3RVRPVFJrLU1EZUYtelE2M1VmNzhOWXlWUFBaYVVwVGV6UG5MemRkVHFqZ2lYbzZkZnJUNmJjbzZwakg3NzhReU95Vzd1OVpQS1RuZktKNDB1R2lmWjdUUHlRcmZOWkFCeHdpd2FNU1E4TUNNTU9RTnpLQW5uSk9kbUxzaldydzZQbU02dGN4bW0zRVJ4VHF1clZGdS1ub093ZUZJZVdiYWduQmF3SVJaYnBhQTZpMTM1a3RhcGMtdzNxeDJjM2pVTU1ELWtWS0ZPakFGTnF6?oc=5","date":"2022-12-21","type":"pipeline","source":"PR Newswire","summary":"Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceutical Packaging - PR Newswire","headline":"Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNVVNlYTJReDFHRjRNdF9WS1Q0Z2xFZU9oUjJkT1pKX3dBakVFdm5TUWFXRkxaZl94Z0xYNFhZUlh6ZTh5a0lNMFl0NzU5cDM2V3Z2XzgtblFwcG1ZS0F4ckl2UlVNMkxGSlhETHA1WUZrNGJOYnI1N3hwVUdabEhNay1FcHc?oc=5","date":"2022-12-14","type":"deal","source":"WashU Medicine","summary":"WashU, Eisai form drug discovery collaboration - WashU Medicine","headline":"WashU, Eisai form drug discovery collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFAyM1R2ZENMTVJoUzcwRmhsWmdickMyZDhxUlNKVG9rcExwTlJaeHJ2b0pQSHVBNHpBMWFFVVlJYmZiblNIaTlSR0ZUZ2tjb1llSU5TT1lJZE1Odw?oc=5","date":"2021-02-19","type":"pipeline","source":"Eisai","summary":"Video Library | About Eisai - Eisai","headline":"Video Library | About Eisai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOT3JZNmZLN29rb3d1UDJQcVJkaFN0bTRJUlliVEdCMW5QQ0tPakFXaG5HbHQ0cFVUWEVhRy1WUS1ZaWhSOW5TSDVCMDlzRllwSkQ4bG5MenJ4ZHlXMzJoWTdxNUpaOHRrOVRxWVlBN2ctY29LSUZ0NS0wUVhWYUxSekE5ckt3RmhYQWc?oc=5","date":"2020-11-16","type":"pipeline","source":"Contract Pharma","summary":"Eisai Invests in New Packaging Lines - Contract Pharma","headline":"Eisai Invests in New Packaging Lines","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_1":2,"marketed":1,"phase_2":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}